SRTA
Strata Critical Medical, Inc. · Healthcare · Medical - Care Facilities
Momentum inputs (comparable managers):
holder breadth +9.1% ·
share flow +2.9% ·
net new positions +8.3%
· formula
Broad accumulation: rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | +1 | 16.12K | $72,070 | +1 | n/a |
| Q2 2026 | 64 | +2 | 30.62M | $161.23M | +5 | −4 |
| Q1 2026 | 65 | -1 | 35.82M | $149.75M | +2 | −3 |
| Q4 2025 | 66 | -2 | 36.14M | $173.84M | n/a | −2 |
| Q3 2025 | 16 | +1 | 24.58M | $124.36M | +2 | −1 |
| Q2 2025 | 12 | +1 | 20.26M | $81.63M | +1 | n/a |
| Q1 2025 | 8 | -1 | 12.11M | $33.06M | n/a | −1 |
| Q4 2024 | 9 | 0 | 12.82M | $54.49M | n/a | n/a |
| Q3 2024 | 8 | +1 | 9.76M | $28.71M | +1 | n/a |
| Q2 2024 | 7 | n/a | 8.74M | $30.43M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | ARK Investment Management ✦ | 8.60M | +5.6% | $34.66M | 0.3% | ▲ Add | 5 | SEC ↗ |
| 2 | BlackRock ✦ (passive) | 4.28M | n/a | $17.25M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 3 | The Vanguard Group ✦ (passive) | 3.30M | n/a | $13.30M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 4 | Geode Capital Management ✦ (passive) | 1.55M | +9.2% | $6.26M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 5 | State Street Global Advisors ✦ (passive) | 1.29M | +2.6% | $5.21M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Renaissance Technologies ✦ | 711.69K | +20.6% | $2.87M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 161.59K | -21.9% | $651,212 | 0.0% | ▼ Trim | 5 | SEC ↗ ×4 |
| 8 | Marshall Wace ✦ | 144.17K | New | $580,994 | 0.0% | New | 1 | SEC ↗ ×2 |
| 9 | Citadel Advisors ✦ | 121.34K | -71.2% | $488,984 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 10 | Millennium Management ✦ | 55.53K | +32.5% | $223,798 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 30.15K | +21.5% | $122,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 12 | Fidelity (FMR) ✦ | 6.49K | n/a | $26,153 | 0.0% | n/c | 1 | SEC ↗ ×2 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Marshall Wace | $580,994 | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 125 holders, 55.49M shares, $231.60M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Director · 5.09K sh · $29,273
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology
5.8% of class · View original SEC filing ↗